Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GTBP - GT Biopharma Inc. (GTBP) CEO Tony Cataldo on Q2 2021 Results - Earnings Call Transcript

GTBP - GT Biopharma Inc. (GTBP) CEO Tony Cataldo on Q2 2021 Results - Earnings Call Transcript

GT Biopharma Inc.
GT Biopharma, Inc. (GTBP) Q2 2021 Earnings Conference Call August 13, 2021 08:30 AM ET Company Participants David Castaneda - Investor Relations Tony Cataldo - Chairman & Chief Executive Officer Martin Schroeder - Chief Technology Officer Greg Berk - Chief Medical Officer Conference Call Participants Justin Walsh - B. Riley Securities Ram Selvaraju - H.C. Wainwright Tony Butler - ROTH Capital Presentation Operator Greetings and welcome to the GT Biopharma Second Quarter 2021 Conference Call. All participants are currently in a listen-only mode. Following the formal presentation, we'll open the call up for a question-and-answer session. At this time, I'd like to turn the conference call over to David Castaneda, Investor Relations for the company. Thank you. You may proceed. David Castaneda Thank you, operator. Good morning, everyone and welcome to GT Biopharma’s second quarter 2021 conference call. Earlier this morning, we issued a press release, summarizing the company's second

For further details see:

GT Biopharma, Inc. (GTBP) CEO Tony Cataldo on Q2 2021 Results - Earnings Call Transcript
Stock Information
Company Name: GT Biopharma Inc.
Stock Symbol: GTBP
Market: OTC
Website: gtbiopharma.com
Menu
GTBP GTBP Quote GTBP Short GTBP News GTBP Articles GTBP Message Board
Get GTBP Alerts

News, Short Squeeze, Breakout and More Instantly...